OPGEN INC (OPGN) Stock Price & Overview
NASDAQ:OPGN • US68373L5057
The current stock price of OPGN is 1.96 USD. Today OPGN is down by -14.78%. In the past month the price decreased by -34.88%. In the past year, price increased by 14.62%.
OPGN Key Statistics
- Market Cap
- 2.646M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -28.18
- Dividend Yield
- N/A
OPGN Stock Performance
OPGN Stock Chart
OPGN Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to OPGN. When comparing the yearly performance of all stocks, OPGN is a bad performer in the overall market: 79.91% of all stocks are doing better.
OPGN Earnings
OPGN Forecast & Estimates
6 analysts have analysed OPGN and the average price target is 3.06 USD. This implies a price increase of 56.12% is expected in the next year compared to the current price of 1.96.
For the next year, analysts expect an EPS growth of 99.72% and a revenue growth -0.26% for OPGN
OPGN Groups
Sector & Classification
OPGN Financial Highlights
Over the last trailing twelve months OPGN reported a non-GAAP Earnings per Share(EPS) of -28.18. The EPS increased by 79.19% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -897.5% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
OPGN Ownership
OPGN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.34 | 401.392B | ||
| AMGN | AMGEN INC | 16.55 | 202.383B | ||
| GILD | GILEAD SCIENCES INC | 16.52 | 184.425B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.4 | 126.804B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.57 | 81.619B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.95 | 42.754B | ||
| INSM | INSMED INC | N/A | 31.007B | ||
| NTRA | NATERA INC | N/A | 28.197B | ||
| BIIB | BIOGEN INC | 11.85 | 27.651B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.24 | 23.485B | ||
| MRNA | MODERNA INC | N/A | 21.714B | ||
| EXAS | EXACT SCIENCES CORP | 340.18 | 19.732B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.591B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About OPGN
Company Profile
OpGen Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Rockville, Maryland. The company went IPO on 2015-05-05. OpGen, Inc. is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The firm distributes molecular microbiology solutions that help guide clinicians with more information about life threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The firm's product portfolio includes Unyvero Lower Respiratory Tract Panels, Unyvero Urinary Tract Infection Panel, Unyvero System, and Unyvero Resources. The Unyvero LRT panels enable comprehensive detection of the most clinically relevant pathogens and antibiotic resistance markers. The Unyvero Urinary Tract Infection (UTI) panel simultaneously identifies a comprehensive range of pathogens and antibiotic resistance markers associated with urinary tract infections. The Unyvero system uses multiplex PCR technology to simultaneously test for a range of microorganisms and antibiotic resistance markers.
Company Info
IPO: 2015-05-05
OPGEN INC
9717 Key West Avenue, Suite 100
Rockville MARYLAND 20878 US
CEO: Oliver Schacht
Employees: 100
Phone: 13018699683
OPGEN INC / OPGN FAQ
What does OPGN do?
OpGen Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Rockville, Maryland. The company went IPO on 2015-05-05. OpGen, Inc. is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The firm distributes molecular microbiology solutions that help guide clinicians with more information about life threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The firm's product portfolio includes Unyvero Lower Respiratory Tract Panels, Unyvero Urinary Tract Infection Panel, Unyvero System, and Unyvero Resources. The Unyvero LRT panels enable comprehensive detection of the most clinically relevant pathogens and antibiotic resistance markers. The Unyvero Urinary Tract Infection (UTI) panel simultaneously identifies a comprehensive range of pathogens and antibiotic resistance markers associated with urinary tract infections. The Unyvero system uses multiplex PCR technology to simultaneously test for a range of microorganisms and antibiotic resistance markers.
Can you provide the latest stock price for OPGEN INC?
The current stock price of OPGN is 1.96 USD. The price decreased by -14.78% in the last trading session.
Does OPGN stock pay dividends?
OPGN does not pay a dividend.
What is the ChartMill technical and fundamental rating of OPGN stock?
OPGN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Which stock exchange lists OPGN stock?
OPGN stock is listed on the Nasdaq exchange.
What is the Short Interest ratio of OPGEN INC (OPGN) stock?
The outstanding short interest for OPGEN INC (OPGN) is 0.23% of its float.